Sign Out
Indicated for the short-term treatment of moderate to severe melasma of the face, in the presence of measures for sun avoidance, including the use of sunscreens.
LUMIQUIN cream contains corticosteroid, retinoid, and depigmenting agent, is not indicated for the maintenance treatment of melasma.
The safety and efficacy of LUMIQUIN cream in the treatment of hyperpigmentation conditions other than melasma of the face have not been studied.
